Atossa Therapeutics Inc (ATOS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 9,251 | 9,040 | 7,414 | 7,151 | 6,385 |
| Operating Income | -9,251 | -9,040 | -7,414 | -7,151 | -6,385 |
| Other Income | 559 | 617 | 696 | 804 | -845 |
| Pre-tax Income | -8,692 | -8,423 | -6,718 | -6,347 | -7,230 |
| Net Income Continuous | -8,692 | -8,423 | -6,718 | -6,347 | -7,230 |
| Net Income | $-8,692 | $-8,423 | $-6,718 | $-6,347 | $-7,230 |
| EPS Basic Total Ops | -1.05 | -1.05 | -0.75 | -0.60 | -0.90 |
| EPS Basic Continuous Ops | -1.01 | -0.98 | -0.78 | -0.75 | -0.86 |
| EPS Diluted Total Ops | -1.05 | -1.05 | -0.75 | -0.60 | -0.90 |
| EPS Diluted Continuous Ops | -1.01 | -0.98 | -0.78 | -0.75 | -0.86 |
| EPS Diluted Before Non-Recurring Items | -1.05 | -1.05 | -0.75 | -0.75 | -0.75 |
| EBITDA(a) | $-9,247 | $-9,036 | $-7,410 | $-7,147 | $-6,381 |